Skip to content

Investigation for biomarkers for "silent progression" in neuromyelitis optica spectrum disorders and multiple sclerosis

Investigation for biomarkers for "silent progression" in neuromyelitis optica spectrum disorders and multiple sclerosis - Observational Study on "Silent Progression" in NMOSD/MS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051660
Enrollment
180
Registered
2023-08-01
Start date
2024-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuromyelitis spectrum disorder, multiple sclerosis

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patients diagnosed with neuromyelitis optica spectrum disorder or multiple sclerosis. 2 Patients fulfilling the 2015 International Panel NMOSD diagnostic criteria for neuromyelitis optica spectrum disorder. 3 Patients fulfilling the 2017 McDonald diagnostic criteria for multiple sclerosis. 4 Adult patients aged 18 years or older when obtaining consent, regardless of gender. 5 Patients from whom consent for participation in this study is obtained in writing by the individual themselves.

Exclusion criteria

Exclusion criteria: 1 Patients with the following complications: Cirrhosis of the liver Acute fulminant hepatitis Congenital amino acid metabolic disorders Severe malnutrition requiring treatment 2 Patients who lack the capacity or willingness to follow instructions for tests, such as fasting blood sampling. 3 Patients deemed unsuitable for participation in this study by the principal investigator or research collaborators.

Design outcomes

Primary

MeasureTime frame
diffusion tensor image analysis along the perivascular space (DTI ALPS) index

Countries

Japan

Contacts

Public ContactHaruhiko Motegi

Keio University School of Medicine Department of Neurology

nakahara@a6.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026